Reassessing the role of HLA-DRB3 T-cell responses: Evidence for significant expression and complementary antigen presentation

European Journal of Immunology

Volumn 40, Issue 1, 2010, Pages 91-102

  Faner, Rosa ^a   James, Eddie ^b   Huston, Laurie ^b   Pujol Borrel, Ricardo ^a,c   Kwok, William W ^b,d   Juan, Manel ^a,e  

^a Laboratory of Immunobiology for Research and Application to Diagnosis (LIRAD)   (Spain)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF WASHINGTON   (United States)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Antigen presentation; APC; Cd4+ t cells; Mhc class ii; Molecular immunology

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; EPITOPE; HLA DR ANTIGEN; HLA DRB3 ANTIGEN; MESSENGER RNA; TETANUS TOXIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; HLA DRB3; HLA-DRB1 ANTIGEN; HLA-DRB3;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; HEAVY CHAIN; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRE T LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; AMINO ACID SEQUENCE; CHEMISTRY; EPITOPE MAPPING; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; B-LYMPHOCYTES; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; MONOCYTES; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 74249118092     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939225     Document Type: Article

References (53)

1. Gonzalez, P. A., Carreno, L. J., Coombs, D., Mora, J. E., Palmieri, E., Goldstein, B., Nathenson, S. G. and Kalergis, A. M., T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc. Natl. Acad. Sci. USA 2005. 102: 4824-4829.
2. Davis, S. J., Ikemizu, S., Evans, E. J., Fugger, L., Bakker, T. R. and van der Merwe, P. A., The nature of molecular recognition by T cells. Nat. Immunol. 2003. 4: 217-224.
3. Bergstrom, T. F., Erlandsson, R., Engkvist, H., Josefsson, A., Erlich, H. A. and Gyllensten, U., Phylogenetic history of hominoid DRB loci and alleles inferred from intron sequences. Immunol. Rev. 1999. 167: 351-365.
4. Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Maner, S. et al., Large-scale copy number polymorphism in the human genome. Science 2004. 305: 525-528.
5. Berdoz, J., Gorski, J., Termijtelen, A. M., Dayer, J. M., Irle, C., Schendel, D. and Mach, B., Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types. J. Immunol. 1987. 139: 1336-1341.
6. Robinson, J., Waller, M. J., Parham, P., Bodmer, J. G. and Marsh, S. G., IMGT/HLA Database - a sequence database for the human major histocompatibility complex. Nucleic Acids Res. 2001. 29: 210-213.
7. Gongora, R., Figueroa, F. and Klein, J., The HLA-DRB9 gene and the origin of HLA-DR haplotypes. Hum. Immunol. 1996. 51: 23-31.
8. Jaraquemada, D., Martin, R., Rosen-Bronson, S., Flerlage, M., McFarland, H. F. and Long, E. O., HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J. Immunol. 1990. 145: 2880-2885.
9. Pette, M., Fujita, K., Wilkinson, D., Altmann, D. M., Trowsdale, J., Giegerich, G., Hinkkanen, A. et al., Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 1990. 87: 7968-7972.
10. Vergelli, M., Kalbus, M., Rojo, S. C., Hemmer, B., Kalbacher, H., Tranquill, L., Beck, H. et al., cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells. J. Neuroimmunol. 1997. 77: 195-203.
11. Wilkinson, D., de Vries, R. R., Madrigal, J. A., Lock, C. B., Morgenstern, J. P., Trowsdale, J. and Altmann, D. M., Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients. J. Exp. Med. 1988. 167: 1442-1458.
12. Khare, M., Mangalam, A., Rodriguez, M. and David, C. S., HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J. Neuroimmunol. 2005. 169: 1-12.
13. Doxiadis, G. G., de Groot, N. and Bontrop, R. E., Impact of endogenous intronic retroviruses on major histocompatibility complex class II diversity and stability. J. Virol. 2008. 82: 6667-6677.
14. Doxiadis, G. G., de Groot, N., de Groot, N. G., Doxiadis, I.I. and Bontrop, R. E., Reshuffling of ancient peptide binding motifs between HLA-DRB multigene family members: old wine served in new skins. Mol. Immunol. 2008. 45: 2743-2751.
15. Dai, S., Crawford, F., Marrack, P. and Kappler, J.W., The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles. Proc. Natl. Acad. Sci. USA 2008. 105: 11893-11897.
16. Sintasath, D. M., Tang, T., Slack, R., Tilley, E. E., Ng, J., Hartzman, R. J. and Hurley, C. K., Relative HLA-DRB1*13 allele frequencies and DRB3 associations of unrelated individuals from five US populations. Hum. Immunol. 1999. 60: 1001-1010.
17. Gans, C. P., Tang, T. F., Slack, R., Ng, J., Hartzman, R. J. and Hurley, C. K., DRB1*14 diversity and DRB3 associations in four major population groups in the United States. Tissue Antigens 2002. 59: 364-369.
18. Tang, T. F., Huang, A. Y., Pappas, A., Slack, R., Ng, J., Hartzman, R. J. and Hurley, C. K., Relative frequencies of DRB1*11 alleles and their DRB3 associations in five major population groups in a United States bone marrow registry. Hum. Immunol. 2000. 61: 820-827.
19. Tang, T. F., Wang, J., Slack, R., Lin, Y. S., Li, L., Heine, U., Ng, J. et al., DRB1*03 diversity and DRB3 associations in five major population groups in the United States. Hum. Immunol. 2002. 63: 221-228.
20. LeGuern, C., Tolerogenic property of MHC class I and class II molecules: lessons from a gene therapy approach. Front Biosci. 2007. 12: 3133-3139.
21. Bontrop, R., Ottenhoff, T., Van Miltenburg, R., Elferink, D., De Vries, R. and Giphart, M., Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity. Eur. J. Immunol. 1986. 16: 133-138.
22. Cotner, T., Charbonneau, H., Mellins, E. and Pious, D., mRNA abundance, rather than differences in subunit assembly, determine differential expression of HLA-DR beta 1 and -DR beta 3 molecules. J. Biol. Chem. 1989. 264: 11107-11111.
23. Vincent, R., Louis, P., Gongora, C., Papa, I., Clot, J. and Eliaou, J. F., Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction. J. Immunol. 1996. 156: 603-610.
24. Louis, P., Pinet, V., Cavadore, P., Kerlan-Candon, S., Clot, J. and Eliaou, J. F., Differential expression of HLA-DRB genes according to the polymorphism of their regulatory region. C. R. Acad. Sci. III 1994. 317: 161-166.
25. Louis, P., Vincent, R., Cavadore, P., Clot, J. and Eliaou, J. F., Differential transcriptional activities of HLA-DR genes in the various haplotypes. J. Immunol. 1994. 153: 5059-5067.
26. Tosi, R., Tanigaki, N., De Preval, C., Gorski, J. and Mach, B., Immuno-chemical analysis of a cell transfected with an HLA-DR gene reveals a new alloantigenic specificity within HLA-DRw52. Eur. J. Immunol. 1986. 16: 1603-1608.
27. Irle, C., Jaques, D., Tiercy, J. M., Fuggle, S. V., Gorski, J., Termijtelen, A., Jeannet, M. and Mach, B., Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones. J. Exp. Med. 1988. 167: 853-872.
28. Texier, C., Pouvelle-Moratille, S., Busson, M., Charron, D., Menez, A. and Maillere, B., Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules. Eur. J. Immunol. 2001. 31: 1837-1846.
29. Wienhold, W., Malcherek, G., Jung, C., Stevanovic, S., Jung, G., Schild, H. and Melms, A., An example of immunodominance: engagement of synonymous TCR by invariant CDR3 beta. Int. Immunol. 2000. 12: 747-756.
30. Nagvekar, N., Corlett, L., Jacobson, L. W., Matsuo, H., Chalkley, R., Driscoll, P. C., Deshpande, S. et al., Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor. J. Immunol. 1999. 162: 4079-4087.
31. Reijonen, H. and Kwok, W. W., Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods 2003. 29: 282-288.
32. James, E. A., Bui, J., Berger, D., Huston, L., Roti, M. and Kwok, W. W., Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+T cells and suggests HLA-based differences in epitope recognition. Int. Immunol. 2007. 19: 1291-1301.
33. Wu, S., Maslanka, K. and Gorski, J., An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J. Immunol. 1997. 158: 3221-3226.
34. Parry, C. S., Gorski, J. and Stern, L. J., Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity. J. Mol. Biol. 2007. 371: 435-446.
35. Verreck, F. A., van de Poel, A., Drijfhout, J. W., Amons, R., Coligan, J. E. and Konig, F., Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52. Immunogenetics 1996. 43: 392-397.
36. Novak, E. J., Liu, A. W., Nepom, G. T. and Kwok, W. W., MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 1999. 104: R63-R67.
37. Prat, E., Tomaru, U., Sabater, L., Park, D. M., Granger, R., Kruse, N., Ohayon, J. M. et al., HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J. Neuroimmunol. 2005. 167: 108-119.
38. Leen, M. P. and Gorski, J., DRB4 promoter polymorphism in DR7 individuals: correlation with DRB4 pre-mRNA and mRNA levels. Immunogenetics 1997. 45: 371-378.
39. Stunz, L. L., Karr, R. W. and Anderson, R. A., HLA-DRB1 and -DRB4 genes are differentially regulated at the transcriptional level. J. Immunol. 1989. 143: 3081-3086.
40. Emery, P., Mach, B. and Reith, W., The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum. Immunol. 1993. 38: 137-147.
41. Bontrop, R. E., Elferink, D. G., Otting, N., Jonker, M. and de Vries, R. R., Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution. J. Exp. Med. 1990. 172: 53-59.
42. Malcherek, G., Gnau, V., Stevanovic, S., Rammensee, H. G., Jung, G. and Melms, A., Analysis of allele-specific contact sites of natural HLA-DR17 ligands. J. Immunol. 1994. 153: 1141-1149.
43. Demotz, S., Lanzavecchia, A., Eisel, U., Niemann, H., Widmann, C. and Corradin, G., Delineation of several DR-restricted tetanus toxin T cell epitopes. J. Immunol. 1989. 142: 394-402.
44. Schreuder, G. M., Hurley, C. K., Marsh, S. G., Lau, M., Fernandez-Vina, M., Noreen, H. J., Setterholm, M. and Maiers, M., The HLA Dictionary 2004: A summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens 2005. 65: 1-55.
45. Sukati, H., Bessos, H., Barker, R. N. and Urbaniak, S. J., Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women. Transfusion 2005. 45: 1165-1177.
46. Gandemer, V., Kaplan, C., Quelvennec, E., Poulain, P., Laurent, M. C., Semana, G., Renouard, J. and Le Gall, E., Pregnancy-associated autoimmune neonatal thrombocytopenia: role of maternal HLA genotype. Br. J. Haematol. 1999. 104: 878-885.
47. Price, P., Santoso, L., Mastaglia, F., Garlepp, M., Kok, C. C., Allcock, R. and Laing, N., Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens 2004. 64: 575-580.
48. Chomczynski, P. and Sacchi, N., The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat. Protoc. 2006. 1: 581-585.
49. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987. 162: 156-159.
50. Armengol, M. P., Cardoso-Schmidt, C. B., Fernandez, M., Ferrer, X., Pujol-Borrell, R. and Juan, M., Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 2003. 170: 6320-6328.
51. Sabater, L., Ferrer-Francesch, X., Sospedra, M., Caro, P., Juan, M. and Pujol-Borrell, R., Insulin alleles and autoimmune regulator (AIRE) gene expression both influence insulin expression in the thymus. J. Autoimmun. 2005. 25: 312-318.
52. Yang, J., Jaramillo, A., Shi, R., Kwok, W.W. and Mohanakumar, T., In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. Hum. Immunol. 2004. 65: 692-699.
53. Yang, J., James, E. A., Huston, L., Danke, N. A., Liu, A. W. and Kwok, W. W., Multiplex mapping of CD4 T cell epitopes using class II tetramers. Clin. Immunol. 2006. 120: 21-32.